BioSpace News Archive

Xencor to Present Data from the Phase 1 Study of Vudalimab (XmAb ® 717) and Four Research Programs at the SITC Annual Meeting

The SBIR/STTR Matching Fund Grant Will Advance the Company’s Innovation and Commercialization Efforts, and Job Creation

Ultimovacs ASA, a clinical stage leader in immune stimulatory vaccines for cancer, announced it has started dosing of the second cohort in the Phase I TENDU trial, evaluating the Company’s Tetanus-Epitope Targeting -platform.

Leading global animal nutrition technology company AB Vista and Avivagen Inc. announced they have entered into a transformative supply agreement that is expected to expand the adoption and use of OxC-betaTM in a number of high-value feed production markets worldwide.

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, announced the grant of an inducement award outside of the Company’s 2019 Stock Incentive Plan to Naomi Aoki, the Company’s newly appointed SVP, Communications and Investor Relations.

Today, TruDiagnostic announced their newest research project; expanding and validating a new cellular deconvolution method to separate epithelial cells from immune cells in saliva samples.

NSF-Funded Network for Advanced NMR Orders Two 1.1 GHz NMR Systems to Advance Protein Structure and Dynamics Research

Enanta Pharmaceuticals, Inc. today announced that the company will have two poster presentations showcasing clinical data for EDP-514, a novel pangenotypic class II hepatitis B virus (HBV) core inhibitor, at The Liver Meeting® 2021

Bristol Myers Squibb (NYSE: BMY) today announced that the company will hold an Investor Event in New York City on Tuesday, November 16, 2021 at 9:30 a.m. ET.

Minovia Therapeutics announced today the publication of preclinical data demonstrating that mitochondrial augmentation of CD34+ cells confers functional benefit and that mitochondrial transfer occurs between hematopoietic cells in vivo.